Black Diamond Therapeutics, Inc. · NASDAQ:BDTX

Black Diamond Therapeutics, Inc. shareholders

As of Sep 30, 2026, 107 institutions reported holding Black Diamond Therapeutics, Inc., 65.8% of its shares. Largest: NEA Management Company, LLC, BlackRock and T. Rowe Price. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Black Diamond Therapeutics, Inc.ChangeFiled
NEA Management Company, LLC4.45M7.7%no changeNov 16, 2026
BlackRock4.3M7.5%+384KNov 13, 2026
T. Rowe Price3.96M6.9%−103KNov 16, 2026
Vanguard2.9M5.0%+38,706Nov 13, 2026
Acadian Asset Management LLC2.35M4.1%no changeNov 9, 2026
Bank of America2.05M3.6%+1.63MNov 16, 2026
Defilade Capital Management, L.P.1.77M3.1%+95,949Nov 16, 2026
Renaissance Technologies1.65M2.9%−310KNov 12, 2026
Geode Capital1.25M2.2%+28,143Nov 6, 2026
Marshall Wace, LLP1.18M2.0%+280KNov 13, 2026

Black Diamond Therapeutics, Inc. insider trades